Nabriva Therapeutics Plc
|Market Cap (Intraday)||63.61M|
|2yr Forward PE||N/A|
Nabriva Therapeutics Plc Stock, NASDAQ:NBRV
Nabriva Therapeutics Plc is a biopharmaceutical company, which engages in the research, development, and commercialization of novel anti-infective agents to treat serious infections. Its product pipeline includes Lefamulin, and CONTEPO. The company was founded in October 2005 and is headquartered in Dublin, Ireland.